PATRICIA CERAVOLO: Open Payments
NPI 1871562306 · SARASOTA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$329 in 14 payments from 6 companies in 2025. Trend: 2023 $144 · 2024 $78 · 2025 $329
Food & beverage: $329
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 4 | $98 |
| GENZYME CORPORATION | 2 | $79 |
| Janssen Biotech, Inc. | 4 | $68 |
| Regeneron Healthcare Solutions, Inc. | 1 | $34 |
| Biofrontera Inc. | 2 | $29 |
| ABBVIE INC. | 1 | $20 |
Products named: DUPIXENT, TALTZ, TREMFYA, RINVOQ, AMELUZ.
Industry payments across FL — which companies pay providers there.
